MELD Score Explained: Assessing Liver Disease Severity

The Model for End-Stage Liver Disease, or MELD score, estimates short-term mortality risk in people with advanced liver disease. It is calculated from laboratory and clinical variables reflecting liver function, blood clotting, kidney function, electrolyte balance, and, in MELD 3.0, serum albumin and sex. A higher score generally indicates greater medical urgency, but the result must be interpreted alongside complications, symptoms, trends, and specialist assessment.

Written by Dr. Taimoor Asghar for taimoorasghar.com.

What Is the MELD Score?

The MELD score is an objective prognostic model developed to estimate short-term mortality in patients with severe chronic liver disease. It was initially designed to predict outcomes after transjugular intrahepatic portosystemic shunt procedures and was subsequently adopted for prioritizing many candidates awaiting liver transplantation.

The score is particularly useful because it relies mainly on measurable laboratory values rather than subjective assessments. In general, worsening liver dysfunction, impaired coagulation, kidney injury, hyponatremia, or low albumin can increase the calculated risk.

For most transplant candidates aged 12 years and older in the United States, the Organ Procurement and Transplantation Network uses MELD 3.0. This updated model replaced MELD-Na for allocation purposes on July 13, 2023.

What Does MELD Stand For?

MELD stands for Model for End-Stage Liver Disease. Despite the name, the score may be calculated at different stages of advanced chronic liver disease, particularly when assessing prognosis, transplant referral, or transplant-list priority.

Variables Used in MELD Calculations

Original MELD score

The original MELD model used three laboratory measurements:

• Serum bilirubin: reflects the liver’s ability to process and excrete bilirubin.
• International normalized ratio: reflects blood-clotting function and the liver’s production of clotting factors.
• Serum creatinine: reflects kidney function, which strongly affects prognosis in advanced cirrhosis.

MELD-Na

MELD-Na added serum sodium to the original variables. Low sodium is common in decompensated cirrhosis and is independently associated with increased mortality among people awaiting liver transplantation.

MELD 3.0

MELD 3.0 updates the coefficients of the previous model and incorporates additional information. The current U.S. allocation calculation may use:

• Serum bilirubin
• International normalized ratio
• Serum creatinine
• Serum sodium
• Serum albumin
• Candidate age at listing
• Sex for the purposes of adult MELD calculation
• Recent dialysis or continuous renal replacement therapy information

MELD 3.0 also includes interaction terms between selected variables. Because the calculation is complex and applies defined upper and lower limits to laboratory values, it should be performed with an official or institution-approved calculator rather than estimated manually.

How the MELD Score Reflects Liver Disease Severity

A higher MELD score generally corresponds to a greater risk of death without transplantation over the short term. The score does not directly measure the amount of liver scarring. Instead, it measures the physiological consequences of advanced liver disease, particularly impaired bilirubin handling, reduced clotting-factor production, kidney dysfunction, abnormal sodium regulation, and low albumin.

The score usually ranges from approximately 6 to 40 within the U.S. transplant allocation system. A score near the lower end generally represents a lower predicted short-term mortality risk, while a score closer to 40 represents very high medical urgency.

General interpretation

These descriptions are intentionally broad. Exact mortality estimates vary according to the MELD version, patient population, clinical setting, and whether the value is being used for transplant allocation or general prognosis.

How Is the MELD Score Used?

Liver transplant prioritization

The best-known use of MELD is to help prioritize many liver transplant candidates according to medical urgency. A higher allocation score generally gives a candidate greater priority, although actual allocation also depends on factors such as blood group, geographic distribution, donor-recipient compatibility, organ characteristics, waiting-list status, and specific allocation policies.

Transplant referral and evaluation

The MELD score may help clinicians decide when referral to a hepatologist or transplant center is appropriate. Referral should not depend on a single cutoff alone. Recurrent ascites, variceal bleeding, hepatic encephalopathy, jaundice, spontaneous bacterial peritonitis, hepatorenal dysfunction, or hepatocellular carcinoma may justify specialist or transplant evaluation even when the laboratory-based score appears modest.

Monitoring changes over time

Serial MELD results may be more informative than one isolated result. A rising score can indicate worsening liver or kidney function, whereas a falling score may reflect improvement following treatment of a reversible problem. Laboratory timing, fluid status, infection, bleeding, medication effects, and renal replacement therapy can all influence the result.

Clinical research and risk stratification

MELD-based models are also used in research, hospital risk assessment, surgical planning, and studies of complications associated with cirrhosis. The applicable model and cutoff should always be specified because original MELD, MELD-Na, and MELD 3.0 are not interchangeable.

Worked Example of Clinical Interpretation

Consider two patients with cirrhosis. The first has mildly increased bilirubin, a near-normal INR, stable creatinine, normal sodium, and preserved albumin. The second has marked jaundice, prolonged INR, worsening creatinine, low sodium, and low albumin.

The second patient would generally receive a substantially higher MELD 3.0 score because several organ-function markers indicate increased short-term mortality risk. However, the final score should be generated using the official calculation rules, and the patient should be assessed for reversible causes such as infection, dehydration, gastrointestinal bleeding, medication-related kidney injury, or urinary obstruction.

Why Kidney Function Matters in Cirrhosis

Kidney dysfunction is a major predictor of poor outcomes in advanced liver disease. Creatinine is therefore an important component of MELD calculations. Causes of an increased creatinine level may include dehydration, infection, gastrointestinal bleeding, nephrotoxic medication exposure, intrinsic kidney disease, or hepatorenal syndrome.

Serum creatinine also has limitations. It can underestimate kidney dysfunction in people with low muscle mass, which is common in advanced cirrhosis. This was one reason the MELD 3.0 model was designed to improve risk prediction and reduce disparities that were not fully addressed by earlier versions.

Why Sodium and Albumin Are Included

Serum sodium

Low serum sodium in cirrhosis often reflects severe circulatory dysfunction and impaired water excretion. Research in liver transplant candidates demonstrated that sodium provided prognostic information beyond the original MELD score, leading to the adoption of MELD-Na and its continued inclusion in MELD 3.0.

Serum albumin

Albumin is produced by the liver and may fall because of impaired synthesis, systemic inflammation, malnutrition, kidney loss, or fluid dilution. Including albumin in MELD 3.0 improves the model’s ability to estimate waiting-list mortality, although albumin remains influenced by factors beyond liver function alone.

MELD Score Limitations

The MELD score is clinically valuable, but it does not capture every important feature of advanced liver disease.

• It is not a complete assessment: ascites, encephalopathy, frailty, malnutrition, sarcopenia, falls, recurrent infections, and quality of life may not be adequately represented.
• Laboratory values can change rapidly: infection, bleeding, dehydration, intravenous fluids, dialysis, anticoagulants, and medications may alter the calculation.
• Creatinine is affected by muscle mass: severe sarcopenia can make kidney dysfunction appear less marked than it actually is.
• Some diseases receive exception points: certain conditions, including selected cases of hepatocellular carcinoma, may carry risks not adequately reflected by the calculated score.
• It does not predict individual outcomes with certainty: MELD estimates risk across populations and cannot determine precisely what will happen to one person.
• Different systems may use different models: transplant programs outside the United States may follow different allocation policies or MELD variants.

MELD Score Versus Child-Pugh Score

Both MELD and Child-Pugh scores are used in chronic liver disease, but they serve different purposes.

The two scores should not automatically be substituted for one another. The most appropriate model depends on the clinical question.

When to Seek Medical Assessment

A person with cirrhosis should seek prompt medical advice for increasing abdominal swelling, new confusion, worsening jaundice, reduced urine output, fever, persistent vomiting, rapid weight gain, or increasing weakness.

Emergency assessment is appropriate for vomiting blood, black tarry stools, severe confusion, fainting, difficulty breathing, severe abdominal pain, marked drowsiness, or signs of shock. These complications can be life-threatening regardless of the latest MELD result.

Practical Points for Using a MELD Calculator

1. Confirm which version is required: original MELD, MELD-Na, or MELD 3.0.
2. Use laboratory results drawn at approximately the same time.
3. Enter values in the units specified by the calculator.
4. Record whether qualifying dialysis or continuous renal replacement therapy has occurred.
5. Use an official or institution-approved calculator that applies the correct value limits and interaction terms.
6. Interpret the result with symptoms, complications, laboratory trends, frailty, and transplant-center guidance.
7. Recalculate when the patient’s clinical condition or laboratory results change.

Key Takeaway

The MELD score is a validated method for estimating short-term mortality in advanced liver disease and prioritizing many liver transplant candidates. MELD 3.0 incorporates bilirubin, INR, creatinine, sodium, albumin, age-related information, sex-related adjustment, and renal replacement therapy details. Although higher scores usually indicate greater urgency, the score does not replace clinical judgment or account fully for every serious complication of cirrhosis.

Medical disclaimer: This article is for education and general information only. It does not diagnose liver disease, determine transplant eligibility, or replace assessment by a hepatologist or transplant team. Laboratory results and MELD calculations should be interpreted by qualified healthcare professionals using the locally applicable model and allocation policy.